To investigate whether normal glucose-tolerant and type II diabetic overweight adults differ in response to weight regain with regard to substrate oxidation and metabolic parameters. METHODS: A total of 15 overweight-obese subjects: seven normal glucose tolerant (NGT) and eight with type II diabetes (DM) were restudied 5 y after significant weight loss. Prediet, after 28 days calorie restriction and at 5 y, subjects were characterised for weight, height, waist-to-hip ratio (WHR) and body composition by dual-energy X-ray absorptiometry. Fasting glucose, insulin, leptin and lipid levels were measured and subjects underwent euglycaemic-hyperinsulinaemic clamp (insulin 0.25 U/kg/h for 150 min). Indirect calorimetry was performed resting and in the final 30 min of the clamp. Dietary assessment was by 4-day dietdiary. RESULTS: Both NGT and DM groups regained weight at 5 y and were not different to prediet. Total body fat (%) and WHR were higher at 5 y compared to prediet in both groups. Fasting glucose was increased in NGT subjects at 5 y, and fasting insulin was higher in both groups at 5 y compared to prediet. Insulin sensitivity (GIR) was similar at 5 y compared to prediet, but at 5 y DM subjects were more insulin resistant than NGT subjects. At 5 y, both DM and NGT groups had significantly reduced basal fat oxidation and no significant suppression of fat oxidation with insulin. Clamp respiratory quotient levels at 5 y were significantly higher in NGT compared to DM subjects. CONCLUSION: Reduced basal fat oxidation, and reduced variation in substrate oxidation in response to insulin develop with fat regain and fasting hyperinsulinaemia in both NGT and DM obese adults.
Introduction
Contrary to past speculation, obese insulin-resistant humans have been shown to exhibit lower basal fat oxidation than lean humans. 1 A prospective clinical study showed that decreased lipid oxidation is a risk factor for weight gain. 2 Increased muscle lipid content has been strongly related to insulin resistance, 3, 4 and may be linked to decreased muscle fat oxidation rather than increased lipid uptake. Failure to increase fat oxidation in response to an oral fat load has been demonstrated in postobese women, 5 which suggests that this metabolic defect may persist post weight-loss. However, it is also known that obese adults demonstrate defective suppression of fat oxidation during insulin infusion, 6 so that under insulin-stimulated conditions, obese humans have higher rates of fat oxidation. This aspect of the insulin resistance syndrome has been termed 'metabolic inflexibility'. Weight loss of 15% body weight has been shown to improve insulin suppression of fat oxidation but did not significantly change rates of basal fat oxidation. 1 It is uncertain whether reduced basal fat oxidation and lack of fat oxidation suppression with insulin infusion are primary or acquired defects. It is also unknown if these defects precede, or are consequent to, the development of obesity and insulin resistance. Whether type II diabetic (DM) humans have different patterns of substrate oxidation in response to weight regain compared to normal glucosetolerant (NGT) obese humans is also unclear.
We have previously reported changes in insulin action, body composition and lipids in a group of 20 obese subjects, half of whom had DM, after 1 month of calorie restriction. 7, 8 We restudied the group 5 y after the initial weight loss to assess whether weight was regained and body composition had changed, and whether fat and carbohydrate (CHO) oxidation differed in NGT and DM subjects in response to weight regain. We also aimed to determine whether insulin action and metabolic parameters had altered in NGT and DM subjects with weight regain.
Methods and procedures

Subjects
In all, 19 of the original 20 subjects were traced. Of these 19, two had moved interstate and were unable to return for restudy, one had a myocardial infarction just prior to the final study and one refused, leaving 15 of the original group. There were eight NGT subjects and seven subjects with DM, a similar distribution to the initial study. 7, 8 The mean age of subjects at 5 y was 54.5711.5 (s.d.) y. There were no significant differences in clinical characteristics at baseline between NGT and DM subjects: age (P ¼ 0.45), weight (P ¼ 0.88), body mass index (BMI) (P ¼ 0.92), waist (P ¼ 0.34), activity levels (P ¼ 0.23). The ratio of male to female subjects was similar (4:3 in the DM and 5:3 in the NGT group). Menopausal status was unchanged during the study. Prediet, subjects with DM were treated with diet alone (n ¼ 2), metformin (n ¼ 1), sulphonylurea (n ¼ 1) or combined metformin and sulphonylurea (n ¼ 3). The study protocol was approved by the St Vincent's Hospital Research Ethics Committee and conducted in accordance with the Helsinki II Declaration.
Experimental procedures
At 5 y prior to this evaluation, subjects were assessed prediet by anthropometry, usual dietary composition, resting metabolic rate (RMR) and indirect calorimetry, body composition, fasting lipids and glucose parameters. A euglycaemichyperinsulinaemic clamp assessed insulin sensitivity. Each person then reduced daily intake by B1000 kcal and subjects were instructed not to change physical activity level. After 28 days of calorie-restricted diet, the assessments were repeated as previously reported. 8 Subjects were unaware of any plan for long-term follow-up at the time of initial study and did not subsequently have any specific nutritional or exercise intervention. Assessments were performed at 5 y as at baseline.
Anthropometric measurements and body composition. Measurements included height, weight, waist (narrowest diameter between xiphoid process and iliac crest) and hip (widest diameter over greater trochanters) circumferences to derive waist-to-hip ratio (WHR). BMI was calculated (weight in kilograms (kg) divided by height (meters squared)). Body composition was assessed using whole-body DXA (Lunar DPX; Lunar Radiation Corp., Madison, WI, USA) with the same machine and software used at 5 y as prediet. Total and regional tissue compositions (fat mass, lean tissue mass and bone mineral content) were measured with a specific central abdominal window as described elsewhere. 9 Central fat measured by dual-energy X-ray absorptionary (DXA) has a strong correlation with computer tomography measurement of abdominal fat 10 and is strongly related to insulin sensitivity.
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Euglycaemic-hyperinsulinaemic clamp. Clamp studies were started at 0800 hours after an overnight fast. Intravenous catheters were inserted into an antecubital vein for infusion of neutral insulin (Actrapid; Novo Nordisk, Denmark) and glucose (25% dextrose) and into a warmed contralateral hand vein for arterialised blood sampling. Fasting blood samples were obtained for measurement of nonesterified fatty acids (NEFAs), lipids, insulin, plasma glucose (FPG), fructosamine and leptin levels. Neutral insulin was infused at 0.25 U/kg/h for 150 min, the same rate as during the prediet clamps. A variable glucose infusion rate was used to maintain glucose levels at 5 mmol/l. The steady-state glucose infusion rate over the final 40 min of the clamp (GIR) provides an index of whole-body insulin sensitivity.
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Indirect calorimetry. Indirect calorimetry (Deltatrac; Datex, Helsinki, Finland) was performed for 30 min before the clamp and at 120-150 min during hyperinsulinaemia using the same instrument for all studies. Resting metabolic rate (RMR) (kcal/day) and substrate oxidation rates (g/min) were calculated.
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Diet and activity assessment. At baseline and 5 y, each subject's diet was assessed by a nutritionist using a 4-day diet-diary (including one weekend day). Standard measures and food models were used to estimate portions. Energy content and macronutrient intake were calculated (FoodWorks, Xyris Software, Brisbane, Australia). Individuals were excluded from dietary analysis if resting energy expenditure, derived from basal indirect calorimetry, exceeded reported intake (under-reporting). Habitual physical activity was assessed by multiplying the hours per week of reported activity by estimated intensity using a validated questionnaire. 15 
Sample analysis
The same methods were used at all study points. FPG was measured by the glucose oxidase method (NOVA 14, Nova Biomedical, Waltham, MA, USA; Charles, MO, USA). Fructosamine was measured as previously described. 16 Serum cholesterol and triglyceride (TG) concentrations were determined spectrophotometrically at 490 nm using enzymatic colorimetric kits (Roche Diagnostics, Basel, Switzerland). NEFA levels were measured by enzymatic colorimetry (NEFA C kit, WAKO Pure Chemical Industries, Osaka, Japan) and LDL apoB was measured by rate immuno-turbidometric method (Roche, In, USA.).
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Statistical analyses
Statistical analyses were performed using general purpose software (Statview; Abacus Concepts, Berkeley, CA,USA). Data are presented as means7se. The data from prediet include measurements only from the subjects restudied at 5 y. We used repeated-measures ANOVA and two-way ANOVA as appropriate to compare DM and NGT groups. Student's paired t-test was used for prediet and 5 y comparisons.
Significance was set at Po0.05.
Results Table 1 shows the anthropometric and body composition measurements prediet and at 5 y. There were no significant differences between DM and NGT groups prediet or at 5 y (Table 1) . Weight (and BMI) had decreased significantly after the diet (96.275.0 vs 89.574.5 kg, Po0.001 and 96.073.9 vs 90.073.5 kg, Po0.001 for NGT and DM groups, respectively), but at 5 y were similar to baseline (Table 1 ). WHR at 5 y was significantly higher than baseline for both NGT and DM subjects (0.9570.04 vs 0.9170.04, P ¼ 0.02 and 0.9170.04 vs 0.8770.03, P ¼ 0.02, respectively). Although weight was unchanged compared to baseline, total fat (% body mass) was significantly higher at 5 y than pre-diet for NGT and DM subjects and lean tissue was proportionally lower at 5 y compared to baseline (Table 1) . Abdominal fat mass at 5 y was similar to baseline. As expected, NGT and DM groups behaved differently regarding FPG and fructosamine levels ( Table 2 ). Mean FPG of DM subjects was significantly higher than NGT subjects at baseline (7.470.9 vs 5.070.2 mmol/l, P ¼ 0.02) and at 5 y (8.571.1 vs 5.870.2 mmol/l, P ¼ 0.02). The groups demonstrated a significantly different pattern of change in FPG with weight regain. In NGT subjects, at 5 y mean FPG had risen to a level significantly higher than baseline (5.870.2 vs 5.070.2 mmol/l, Po0.05). At 5 y, three subjects in the NGT group had FPG 46.1 mmol/l, but o7 mmol/l. In DM subjects, FPG was not significantly higher than pre-diet, however metformin had been commenced in two subjects, with four subjects taking combined metformin and sulphonylurea, two metformin alone, while one subject remained diet treated.
In both groups, fasting insulin levels at 5 y were significantly higher than prediet (Table 2) . Mean insulin levels were not significantly different between DM and NGT groups prediet or at 5 y. Whole-body insulin sensitivity was similar to prediet at 5 y (Table 2) , but by 5 y, DM subjects were significantly more insulin resistant than NGT subjects (GIR 6.171.8 vs 13.271.6 mmol/kg/min, Po0.01). Basal NEFAs were similar in both groups, with mean levels at 5 y similar to pre-diet. In contrast, clamp NEFAs were different between groups, being significantly higher at 5 y in DM subjects Po0.05, prediet vs 5 y (paired t-test). No significant differences between DM or NGT groups prediet or at 5 y (two-way ANOVA). BMI, body mass index; WHR, waist-to-hip ratio. Obese adults 5 y after weight loss AM Poynten et al compared to NGT subjects (0.2770.08 vs 0.0970.01 mmol/l, Po0.05). Table 3 shows the changes in lipid parameters during the study. LDL, HDL and TG levels were not different to baseline at 5 y. LDL ApoB levels were significantly higher at 5 y compared to prediet levels in both NGT and DM groups (0.7270.07 vs 0.9570.09 mmol/l, Po0.01 and 0.8170.07 vs 1.0870.04 mmol/l, Po0.05, respectively).
In both DM and NGT groups, there was a significant increase in basal respiratory quotient RQ at 5 y compared to prediet, reflecting decreased basal fat oxidation (Table 2) . Clamp RQ did show a significant difference between the groups, with higher clamp RQ at 5 y in the NGT vs DM subjects (0.9070.02 vs 0.8470.02, P ¼ 0.03). Changes in substrate metabolism over the study period are shown in Figures 1 and 2 . At 5 y, basal fat oxidation was significantly lower compared to prediet in both NGT and DM groups (0.4570.19 vs 1.1670.14 mg/min/kg fat-free mass (FFM), P ¼ 0.03; 0.6970.21 vs 0.1770.10 mg/min/kg FFM, P ¼ 0.03 respectively). Basal CHO oxidation was increased at 5 y compared to prediet in both groups (Figure 2) . Prediet, both groups had significant suppression of fat oxidation with insulin infusion (final 30 min of clamp, 1.1670.14 vs 0.7070.12 mg/min/kg FFM, P ¼ 0.01 and 1.1770.13 vs 0.7170.10, P ¼ 0.01 for NGT and DM groups, respectively). At 5 y, there was no significant suppression of fat oxidation with insulin infusion in either NGT or DM groups (Figure 1) . Prediet, CHO oxidation increased significantly with insulin infusion in both NGT and DM subjects but not at 5 y in either group (Figure 2 ). There were no differences between NGT and DM groups in fat or CHO oxidation prediet or at 5 y. Results for substrate oxidation were similar when not corrected for FFM (data not shown).
Reported dietary intake in the DM and NGT groups did not differ during the study, so results are presented as a group (Table 4) . Two subjects were excluded from analysis because of under-reporting intake at 5 y (resting basal energy expenditure over 24 h alone, derived from basal indirect calorimetry, exceeded their reported daily energy intake). At 5 y, reported daily energy intake was not significantly different from prediet (71667628 vs 912171093 kJ, P ¼ 0.07). There was a nonsignificant trend to lower fat intake (% energy) at 5 y compared to prediet (2673 vs 3372.4%, P ¼ 0.05). There was no difference in reported CHO intake (% energy) at 5 y (44.974.5 vs 40.572.9%, P ¼ 0.16). Self-reported activity levels did not change over the 5 y (data not shown).
Discussion
The 15 overweight-obese subjects, half with type II diabetes and half with normal glucose tolerance, who were restudied Obese adults 5 y after weight loss AM Poynten et al 5 y after a 1-month calorie-reduced diet, had regained weight to a level nonsignificantly higher than prediet. Subject selection bias is minimal as only one subject refused follow up assessments. The weight regain confirms other long-term follow-up studies of both NGT and DM adults in the obese range after conventional medical follow-up. 17, 18 Our study is one of the few long-term follow-up studies to have obtained detailed metabolic and body composition assessments. In relation to body composition, both groups were well matched prediet and were not different at 5 y. At 5 y, although weight was not different from prediet, total fat mass had increased while lean mass did not recover after initial weight-loss, despite fat gain usually being associated with an increased lean mass. 19 The group was generally sedentary, which may have favoured the gain of fat rather than lean tissue. None of the women changed menopausal status which may cause body composition change 20 and none of the subjects was elderly where lean mass has been reported to fall. 21 WHR had also increased at 5 y in both groups, consistent with an adverse change in body shape and composition. Whole-body insulin sensitivity, measured by GIR in the euglycaemic clamp, was similar at 5 y to prediet. At 5 y, DM subjects were significantly more insulin resistant than NGT subjects. However, both groups at 5 y had become relatively hyperinsulinaemic. NGT subjects at 5 y had a clinically significant rise in FPG, with three subjects developing impaired fasting glucose. 22 In DM subjects, glycaemic control, reflected in FPG and fructosamine, at 5 y had deteriorated to a nonsignificantly higher level than baseline, despite increased diabetic medication. Clamp NEFA levels were significantly higher in DM subjects at 5 y, supporting the clamp GIR data indicating that DM subjects were more insulin resistant than NGT subjects at 5 y, but not at baseline. Fasting lipid parameters deteriorated with weight regain in DM and NGT groups. Total and LDL cholesterol were not different from prediet levels, but subjects in both groups had higher LDL apoB levels, which are associated with increased cardiovascular risk. 23, 24 Cross-sectional studies have demonstrated that obese insulin-resistant (compared to lean insulin-sensitive) humans have reduced levels of basal fat oxidation with normal fatty acid uptake by skeletal muscle.
1 Therefore, lower fat oxidation during fasting may be a key mechanism leading to excess lipid accumulation within skeletal muscle which has been associated with insulin resistance. 4 Our longitudinal study shows that reduced basal fat oxidation can be an acquired, rather than a primary, defect or at least may become more pronounced. At 5 y, both groups had similar weight and BMI compared to prediet, but had significantly more body fat, increased fasting hyperinsulinaemia and significantly lower basal fat oxidation. The similarity in change in basal substrate oxidation in NGT and DM groups suggests that long-term changes in substrate oxidation may be more attributable to increasing adiposity and hyperinsulinaemia, characteristics that were very similar between the groups, rather than hyperglycaemia (and relative B cell failure) which was more pronounced in the DM group. However, fasting hyperglycaemia may be a contributing factor in the development of increased basal CHO oxidation, oxidation in response to insulin may be a basic defect. 7 Our study, however, suggests that this defect can rather be acquired, or exaggerated, with increasing adiposity. Prior to the calorie-reduced diet, mildly obese NGT and DM subjects showed approximately 40% suppression of fat oxidation with insulin infusion whereas at 5 y, neither NGT nor DM subjects had significant suppression. The development of this defect may also be attributable to increasing adiposity and basal hyperinsulinaemia in both groups. Although we showed no significant difference between DM and NGT groups in the development of this defect, it may be that with larger groups, the ability to vary substrate oxidation with insulin stimulation may parallel the degree of insulin resistance. This is suggested by our finding that at 5 y, clamp RQ was significantly lower in the DM compared to the NGT group, suggesting proportionally higher clamp fat oxidation in DM than NGT subjects and a more severe defect. There is some evidence of a modest influence of habitual fat intake on basal fat oxidation, 27, 28 but this is unlikely to be a major factor in our study given the small, nonsignificant, reduction in dietary fat intake reported at 5 y compared to baseline. The study by Kunz et al suggested that an increase in fat intake of 10 g/day was associated with an increase in basal fat oxidation of 2 g/day. In our study, mean reported fat consumption was nonsignificantly decreased by B30 g fat/ day, which therefore may account (using the ratio from Kunz et al) for a reduction in basal fat oxidation of 6 g/day. In our study (in equivalent units), the mean difference in basal fat oxidation over a 24-h period was 43 g. Therefore, the change in basal fat intake may account for only B14% of the change in basal fat oxidation at 5 y demonstrated in our study. There was no significant difference in mean reported CHO intake (in % or kJ) at 5 y, and therefore basal CHO intake should not have significantly contributed to the increase in basal CHO oxidation demonstrated at 5 y. There is evidence that weight loss improves the responsiveness of substrate oxidation to insulin infusion 1 and our study suggests that increased adiposity blunts this response, but there is little data on the effects of dietary composition on insulin-infused substrate oxidation.
The confounding phenomenon of under-reporting dietary intake, which may be exacerbated when subjects have participated in a weight-loss study, was addressed by excluding those subjects whose reported energy intake was less than resting basal energy expenditure. However, it has previously been reported that obese subjects specifically under-report fat intake. 29 This selective underreporting may be, at least in part, responsible for the trend to lower reported fat intake in our study. In summary, while evidence exists that sustained weight loss is beneficial in obesity, 30 our study again confirms that a single period of calorie reduction, without further intervention, is unsuccessful in the long term. The initial weight loss of approximately 5% of body weight had reported metabolic benefits, 7, 8 but over 5 y fat mass increased without regain in lean mass. There was progression of metabolic defects with increased adiposity in both diabetic and normal glucosetolerant subjects. This study demonstrates that reduced fasting fat oxidation, with reciprocal increased fasting CHO oxidation, develops longitudinally in the presence of increased adiposity and hyperinsulinaemia. The related phenomenon of 'metabolic inflexibility', the inability to suppress fat oxidation with insulin stimulation, appears from these data to be an acquired rather than an intrinsic defect in mildly obese subjects. Metabolic inflexibility developed longitudinally in both NGT and diabetic obese humans.
Whether the defect of insulin suppression of lipid oxidation is more severe in diabetic humans requires further study.
